Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Inflammatory Bowel Diseases

  Free Subscription


31.05.2021

5 Aliment Pharmacol Ther
2 Am J Gastroenterol
3 Clin Gastroenterol Hepatol
1 Dig Dis Sci
3 Eur J Gastroenterol Hepatol
2 Gastroenterol Hepatol
1 Gastroenterology
8 Inflamm Bowel Dis
1 J Clin Gastroenterol
1 J Crohns Colitis
1 Lancet Gastroenterol Hepatol
3 PLoS One
1 Scand J Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. TANNOURY J, Amiot A
    Editorial: determining disability in inflammatory bowel disease-"See(k) and you shall find". Authors' reply.
    Aliment Pharmacol Ther. 2021;53:1323.
    PubMed        

  2. SEDANO R, Ma C, Jairath V
    Editorial: standardising inclusion and outcome criteria for pouchitis-a fragile consensus perhaps but a first step in the right direction. Authors' reply.
    Aliment Pharmacol Ther. 2021;53:1149-1150.
    PubMed        

  3. LAUBE R, Selinger CP
    Editorial: standardising inclusion and outcome criteria for pouchitis-a fragile consensus perhaps but a first step in the right direction.
    Aliment Pharmacol Ther. 2021;53:1147-1148.
    PubMed        

  4. TANNOURY J, Nachury M, Martins C, Serrero M, et al
    Determinants of IBD-related disability: a cross-sectional survey from the GETAID.
    Aliment Pharmacol Ther. 2021;53:1098-1107.
    PubMed         Abstract available

  5. TJANDRA D, Garg M, Behrenbruch C, McCormick J, et al
    Review article: investigation and management of internal fistulae in Crohn's disease.
    Aliment Pharmacol Ther. 2021;53:1064-1079.
    PubMed         Abstract available


    Am J Gastroenterol

  6. BOTWIN GJ, Li D, Figueiredo J, Cheng S, et al
    Adverse Events Following SARS-CoV-2 mRNA Vaccination: Among Patients with Inflammatory Bowel Disease.
    Am J Gastroenterol. 2021 May 25. pii: 00000434-900000000-98766.
    PubMed         Abstract available

  7. DE GIORGI V, Trane L, Silvestri F, Venturi F, et al
    Pyodermatitis-Pyostomatitis Vegetans in Active Inflammatory Bowel Disease.
    Am J Gastroenterol. 2021 May 31. pii: 00000434-900000000-98762.
    PubMed        


    Clin Gastroenterol Hepatol

  8. BERINSTEIN JA, Sheehan J, Dias M, Berinstein EM, et al
    Tofacitinib for Biologic-Experienced Hospitalized Patients with Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study.
    Clin Gastroenterol Hepatol. 2021 May 25. pii: S1542-3565(21)00576.
    PubMed         Abstract available

  9. KAYAL M, Ungaro RC, Riggs A, Kamal K, et al
    Ileal Pouch Anal Anastomosis for the Management of Ulcerative Colitis is Associated with Significant Disability.
    Clin Gastroenterol Hepatol. 2021 May 22. pii: S1542-3565(21)00571.
    PubMed         Abstract available

  10. AHMED W, Scott FI
    Closing the gap: the real-world risk of serious infections with vedolizumab in comparison to anti-TNF therapy in inflammatory bowel disease.
    Clin Gastroenterol Hepatol. 2021 May 19. pii: S1542-3565(21)00564.
    PubMed        


    Dig Dis Sci

  11. AL KHOURY A, Balram B, Bessissow T, Afif W, et al
    Patient Perspectives and Expectations in Inflammatory Bowel Disease: A Systematic Review.
    Dig Dis Sci. 2021 May 21. pii: 10.1007/s10620-021-07025.
    PubMed         Abstract available


    Eur J Gastroenterol Hepatol

  12. ANGELINO G, Cifaldi C, Zangari P, Di Cesare S, et al
    Gastric cancer, inflammatory bowel disease and polyautoimmunity in a 17-year-old boy: CTLA-4 deficiency successfully treated with Abatacept.
    Eur J Gastroenterol Hepatol. 2021 May 21. pii: 00042737-900000000-97208.
    PubMed         Abstract available

  13. VOHRA I, Attar B, Haghbin H, Mutneja H, et al
    Incidence and risk factors for 30-day readmission in ulcerative colitis: nationwide analysis in biologic era.
    Eur J Gastroenterol Hepatol. 2021 May 21. pii: 00042737-900000000-97210.
    PubMed         Abstract available

  14. GATOPOULOU A, Christodoulou DK, Katsanos KH, Bakos D, et al
    Effect of golimumab on health-related quality of life, other patient-reported outcomes and healthcare resource utilization in patients with moderate-to-severe ulcerative colitis: a real-world multicenter, noninterventional, observational study in Gree
    Eur J Gastroenterol Hepatol. 2021 May 21. pii: 00042737-900000000-97217.
    PubMed         Abstract available


    Gastroenterol Hepatol

  15. PEREZ DE ARCE E, Quera R, Beltran CJ, Madrid AM, et al
    Irritable Bowel Syndrome in Inflammatory Bowel Disease. Synergy in alterations of the gut-brain axis?
    Gastroenterol Hepatol. 2021 May 20. pii: S0210-5705(21)00143.
    PubMed         Abstract available

  16. SEMPERE L, Bernabeu P, Cameo J, Gutierrez A, et al
    Evolution of the emotional impact in patients with early Inflammatory Bowel Disease during and after Covid-19 lockdown.
    Gastroenterol Hepatol. 2021 May 20. pii: S0210-5705(21)00145.
    PubMed        


    Gastroenterology

  17. KHAN N, Mahmud N
    Effectiveness of SARS-CoV-2 vaccination in a Veterans Affairs Cohort of Inflammatory Bowel Disease Patients with Diverse Exposure to Immunosuppressive Medications.
    Gastroenterology. 2021 May 25. pii: S0016-5085(21)03066.
    PubMed         Abstract available


    Inflamm Bowel Dis

  18. TAXONERA C, Alba C, Olivares D, Martin M, et al
    Innovation in IBD Care During the COVID-19 Pandemic: Results of a Cross-Sectional Survey on Patient-Reported Experience Measures.
    Inflamm Bowel Dis. 2021;27:864-869.
    PubMed         Abstract available

  19. OLIVER BJ, Kennedy AM, van Deen WK, Weaver SA, et al
    Development of Balanced Whole System Value Measures for Inflammatory Bowel Disease Care in the IBD Qorus Collaborative Using a Modified Delphi Process.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284056. doi: 10.1093.
    PubMed         Abstract available

  20. MORRIS GA, McNicol M, Boyle B, Donegan A, et al
    Increasing Biosimilar Utilization at a Pediatric Inflammatory Bowel Disease Center and Associated Cost Savings: Show Me the Money.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284046. doi: 10.1093.
    PubMed         Abstract available

  21. PENA-SANCHEZ JN, Osei JA, Marques Santos JD, Jennings D, et al
    Increasing Prevalence and Stable Incidence Rates of Inflammatory Bowel Disease Among First Nations: Population-Based Evidence From a Western Canadian Province.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284047. doi: 10.1093.
    PubMed         Abstract available

  22. SHAFFER SR, Erondu AI, Traboulsi C, Rai V, et al
    Achieving Histologic Normalization in Ulcerative Colitis Is Associated With a Reduced Risk of Subsequent Dysplasia.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284061. doi: 10.1093.
    PubMed         Abstract available

  23. LI H, Shu H, Tian F
    Distinct Entity of Inflammatory Bowel Disease in Autoimmune Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2021 May 27. pii: 6285983. doi: 10.1093.
    PubMed        

  24. GAZOULI M, Dovrolis N, Bourdakou MM, Gizis M, et al
    Response to Anti-alpha4beta7 Blockade in Patients With Ulcerative Colitis Is Associated With Distinct Mucosal Gene Expression Profiles at Baseline.
    Inflamm Bowel Dis. 2021 May 27. pii: 6285911. doi: 10.1093.
    PubMed         Abstract available

  25. LIU JJ
    Disparity in the Care of black Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2021 May 25. pii: 6284055. doi: 10.1093.
    PubMed        


    J Clin Gastroenterol

  26. ZAMSTEIN O, Glusman Bendersky A, Sheiner E, Landau D, et al
    Association Between Mode of Delivery of the Breech Fetus and Hospitalizations Due to Inflammatory Bowel Disease During Childhood.
    J Clin Gastroenterol. 2021 May 28. pii: 00004836-900000000-97416.
    PubMed         Abstract available


    J Crohns Colitis

  27. FUMERY M, Chatelain D
    Histological Scores in Inflammatory Bowel Disease: A New Kid in the Block.
    J Crohns Colitis. 2021 May 27. pii: 6286012. doi: 10.1093.
    PubMed        


    Lancet Gastroenterol Hepatol

  28. ALEXANDER JL, Powell N
    SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?
    Lancet Gastroenterol Hepatol. 2021 May 25. pii: S2468-1253(21)00184.
    PubMed        


    PLoS One

  29. TREFZER R, Elpeleg O, Gabrusskaya T, Stepensky P, et al
    Characterization of a L136P mutation in Formin-like 2 (FMNL2) from a patient with chronic inflammatory bowel disease.
    PLoS One. 2021;16:e0252428.
    PubMed         Abstract available

  30. BUSINGYE D, Pollack A, Chidwick K
    Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study.
    PLoS One. 2021;16:e0252458.
    PubMed         Abstract available

  31. YEN HH, Su PY, Huang SP, Wu L, et al
    Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study.
    PLoS One. 2021;16:e0252286.
    PubMed         Abstract available


    Scand J Gastroenterol

  32. LOPEZ-SERRANO A, Suarez MJ, Beso P, Algarra A, et al
    Virtual chromoendoscopy with iSCAN as an alternative method to dye-spray chromoendoscopy for dysplasia detection in long-standing colonic inflammatory bowel disease: a case-control study.
    Scand J Gastroenterol. 2021 May 27:1-9. doi: 10.1080/00365521.2021.1925339.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: